tirzepatide blood thinner FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Retatrutide vs Tirzepatide (2026): Differences

A calorie deficit happens when you consume fewer calories than your body burns , encouraging your body to use stored fat for energy

Tirzepatide (Mounjaro, Zepbound) is a once-weekly subcutaneous injection approved by the FDA for type 2 diabetes management and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Once your prescription is approved, youll only need to provide new photos if your medical details change or if we request them during a follow-up weight loss consultation

Its widely prescribed under the brand names Ozempic for diabetes and Wegovy for weight management